Infoblox (BLOX) Prices 5M Secondary Offering at $20/Share
Get Alerts BLOX Hot Sheet
Join SI Premium – FREE
Infoblox (NYSE: BLOX) announced the pricing of its secondary public offering of 5,000,000 shares of its common stock at a price to the public of $20.00 per share. All of the shares are being sold by existing stockholders of the company. The underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares of common stock from certain of the selling stockholders. As part of the offering, all selling stockholders and certain other stockholders have agreed to lock-up agreements that will extend the initial public offering lock-up period on their remaining shares until 90 days after this offering.
Infoblox will not receive any proceeds from the sale of the shares in this offering. The principal purposes of the offering are to facilitate an orderly distribution of the company’s outstanding shares and increase the company’s public float.
Morgan Stanley & Co. LLC and Goldman, Sachs & Co. are acting as lead joint book-running managers for the offering, UBS Securities LLC is serving as a joint book-running manager for the offering, and Pacific Crest Securities LLC, JMP Securities LLC and Stephens Inc. are serving as co-managers for the offering.
Infoblox will not receive any proceeds from the sale of the shares in this offering. The principal purposes of the offering are to facilitate an orderly distribution of the company’s outstanding shares and increase the company’s public float.
Morgan Stanley & Co. LLC and Goldman, Sachs & Co. are acting as lead joint book-running managers for the offering, UBS Securities LLC is serving as a joint book-running manager for the offering, and Pacific Crest Securities LLC, JMP Securities LLC and Stephens Inc. are serving as co-managers for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
- Gaxos.ai (GXAI) files for 6.17M share offering by selling stockholders
- Nautilus Biotechnology (NAUT) files $300M mixed shelf
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
UBS, Morgan Stanley, JMP Securities, Stephens Inc., Pacific Crest SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share